Literature DB >> 1617529

Epidemiology of congestive heart failure: Canadian data from 1970 to 1989.

J M Brophy1.   

Abstract

OBJECTIVE: To assess mortality rates from congestive heart failure in Canada from 1970 to 1989.
DESIGN: Observational, retrospective design using national population and mortality data. MAIN
RESULTS: There is a definite age gradient for deaths from congestive heart failure which, combined with a general ageing of the Canadian population, has lead to an increase in the absolute number of deaths. However, Standardized Mortality Ratios, which account for shifting population distributions, have shown steadily decreasing values for both men and women since 1980.
CONCLUSIONS: Recent improvements in cardiology care demonstrated in controlled clinical trials appear also to be present in epidemiological studies.

Entities:  

Mesh:

Year:  1992        PMID: 1617529

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  6 in total

1.  Epidemiological burden of heart failure.

Authors:  L Tavazzi
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

Review 2.  Underutilisation of ACE inhibitors in patients with congestive heart failure.

Authors:  T J Bungard; F A McAlister; J A Johnson; R T Tsuyuki
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Exercise for patients with congestive heart failure.

Authors:  R J Shephard
Journal:  Sports Med       Date:  1997-02       Impact factor: 11.136

Review 4.  Current status of the epidemiology of heart failure.

Authors:  W B Kannel
Journal:  Curr Cardiol Rep       Date:  1999-05       Impact factor: 2.931

Review 5.  Incidence and epidemiology of heart failure.

Authors:  W B Kannel
Journal:  Heart Fail Rev       Date:  2000-06       Impact factor: 4.214

6.  Trends and ethnic differences in hospital admissions and mortality for congestive heart failure in the elderly in Singapore, 1991 to 1998.

Authors:  T P Ng; M Niti
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.